[ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#Head", "@graph": [ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#pubInfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#provenance", "@graph": [ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#assertion", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2021-08-16T20:58:21.683895", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ] } ] }, { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#assertion", "@graph": [ { "@id": "http://purl.obolibrary.org/obo/MONDO_0100081", "@type": [ "https://w3id.org/biolink/vocab/Disease" ] }, { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#association", "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [ { "@id": "http://purl.obolibrary.org/obo/MONDO_0100081" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [ { "@id": "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [ { "@id": "https://identifiers.org/DRUGBANK:DB00370" } ], "@type": [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Among TCAs, doxepin (sinequan) appears to be best suited for managing insomnia in healthy adults. Doxepin works as a selective antagonist to H(1) receptors, which promote the initiation and maintenance of sleep (Owen, 2009) (Table 2 contains information on trazodone and mirtazapine). Ultra-low doses of this drug (< 6 mg per day) significantly improve and sustain both maintenance and duration of sleep (Rojas-Fernandez and Chen, 2014; Weber et al., 2010). Another frequently prescribed TCA is amitriptyline, which as a long-term option is found to be effective for patients with ongoing sleep problems (Everitt et al., 2014; Pagel and Parnes, 2001)." } ], "https://w3id.org/biolink/vocab/has_population_context": [ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#context" } ], "https://w3id.org/biolink/vocab/provided_by": [ { "@id": "https://w3id.org/um/NeuroDKG" } ], "https://w3id.org/biolink/vocab/publications": [ { "@id": "https://pubmed.ncbi.nlm.nih.gov/31622593" } ], "https://w3id.org/biolink/vocab/relation": [ { "@id": "https://w3id.org/um/neurodkg/OffLabelIndication" } ] }, { "@id": "https://identifiers.org/DRUGBANK:DB00370", "@type": [ "https://w3id.org/biolink/vocab/Drug" ] }, { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#context", "@type": [ "https://w3id.org/biolink/vocab/Cohort" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Adults" } ] } ] }, { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#pubInfo", "@graph": [ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "QuD/6CVjfKGi5a6X661Abu1gVTwMQ0XkPK5Q6yEDBoPapb1EcKGnEaZT0ESI23TxyUt2i7O3cLR8JxyP0tZHytYhHG6T0neYZIkNi6E8mdUgmeGadsvEKPwxSc1ovY8rORS2PybzJ3JxpLZwcNOGJOi8wBqHlc6AboPIXy+Hd6Q=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA" } ] }, { "@id": "http://purl.org/np/RAqCvrlrWXBYXGaSibHkaus6jdDpT0Z-AkWBsBOFX_FFA", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2021-08-16T20:58:21.683895", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-7641-6446" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] } ] } ]